StocksMedium•3 November 2026•
1 min read
Fresenius Medical Care Narrows Annual Guidance Following Q3 Earnings Decline
Key Facts
1Fresenius Medical Care reported stable organic revenue for Q3, but reported earnings fell due to inflation and China strategy costs.
2The company narrowed its full-year operating income guidance to flat to negative mid-single digits.
Fresenius Medical Care reported stable organic revenue for the third quarter of 2026, though reported earnings declined. TradingView reported that the drop was driven by inflationary headwinds, costs associated with the company's strategic initiatives in China, and ongoing regulatory challenges.
The company narrowed its full-year operating income guidance to a range between flat and a negative mid-single-digit decline. In equity markets, FMS closed at $22.61 on November 2, 2026, while FSNUY closed at $13.56 on the same date.